Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Mol Med Rep. 2017 Dec;16(6):8819-8825. doi: 10.3892/mmr.2017.7681. Epub 2017 Oct 2.
The development of an efficient delivery system is critical for the successful treatment of cardiovascular diseases using non‑viral gene therapies. Cytoplasmic and nuclear membrane barriers reduce delivery efficiency by impeding the transfection of foreign genes. Thus, a gene delivery system capable of transporting exogenous genes may improve gene therapy. The present study used a novel strategy involving ultrasound‑targeted microbubbles and peptide nucleic acid (PNA)‑binding nuclear localization signals (NLS). Ultrasound‑targeted microbubble destruction (UTMD) and PNA‑binding NLS were used to improve the cytoplasmic and nuclear importation of the plasmid, respectively. Experiments were performed using antibody‑targeted microbubbles (AT‑MCB) that specifically recognize the SV40T antigen receptor expressed on the membranes of 293T cells, resulting in the localization of ultrasound microbubbles to 293T cell membranes. Furthermore, PNA containing NLS was inserted into the enhanced green fluorescent protein (EGFP)‑N3 plasmid DNA (NLS‑PNA‑DNA), which increased nuclear localization. The nuclear import and gene expression efficiency of the AT‑MCB with PNA‑binding NLS were compared with AT‑MCB alone or a PNA‑binding NLS. The effect of the AT‑MCB containing PNA‑binding NLS on transfection was investigated. The ultrasound and AT‑MCB delivery significantly enhanced the cytoplasmic intake of exogenous genes and maintained high cell viability. The nuclear import and gene expression of combined microbubble‑ and PNA‑transfected cells were significantly greater compared with cells that were transfected with AT‑MCB or DNA with only PNA‑binding NLS. The quantity of EGFP‑N3 plasmids in the nuclei was increased by >5.0‑fold compared with control microbubbles (CMCB) and NLS‑free plasmids. The gene expression was ~1.7‑fold greater compared with NLS‑free plasmids and 1.3‑fold greater compared with control microbubbles. In conclusion, UTMD combined with AT‑MCB and a PNA‑binding NLS plasmid significantly improved transfection efficiency by increasing cytoplasmic and nuclear DNA import. This method is a promising strategy for the noninvasive and effective delivery of target genes or drugs for the treatment of cardiovascular diseases.
高效递药系统的开发对于应用非病毒基因疗法治疗心血管疾病至关重要。细胞质和核膜屏障通过阻碍外源基因的转染而降低递药效率。因此,能够转运外源基因的基因递药系统可能会提高基因治疗效果。本研究采用了一种新的策略,涉及超声靶向微泡和肽核酸(PNA)结合核定位信号(NLS)。超声靶向微泡破坏(UTMD)和 PNA 结合 NLS 分别用于提高质粒的细胞质和核内导入。实验采用针对 293T 细胞膜上表达的 SV40T 抗原受体的抗体靶向微泡(AT-MCB)进行,导致超声微泡定位于 293T 细胞膜。此外,含有 NLS 的 PNA 被插入增强型绿色荧光蛋白(EGFP)-N3 质粒 DNA(NLS-PNA-DNA)中,从而增加了核定位。比较了含有 PNA 结合 NLS 的 AT-MCB 的核内导入和基因表达效率与单独的 AT-MCB 或 PNA 结合 NLS。考察了含有 PNA 结合 NLS 的 AT-MCB 对转染的影响。超声和 AT-MCB 递药显著增强了外源性基因的细胞质摄取,并保持了高细胞活力。与单独用 AT-MCB 或仅用 PNA 结合 NLS 的质粒转染的细胞相比,联合微泡和 PNA 转染细胞的核内导入和基因表达显著增加。与对照微泡(CMCB)和无 NLS 质粒相比,EGFP-N3 质粒的核内数量增加了 >5.0 倍。与无 NLS 质粒相比,基因表达增加了~1.7 倍,与对照微泡相比,基因表达增加了 1.3 倍。总之,UTMD 联合 AT-MCB 和 PNA 结合 NLS 质粒通过增加细胞质和核内 DNA 导入显著提高了转染效率。该方法为治疗心血管疾病的靶向基因或药物的非侵入性和有效递药提供了一种有前途的策略。